Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disorders

Clinical Neuropharmacology

Volumn 32, Issue 5, 2009, Pages 239-242

  Golubchik, Pavel ^a,b   Sever, Jonathan ^a,b   Weizman, Abraham ^a,b  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adjustment and personality disorders; Attention deficit hyperactivity disorder (ADHD); Stimulants

Indexed keywords

METHYLPHENIDATE; NICOTINE;

ADOLESCENT; ADOLESCENT SMOKING; ADULT; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; BORDERLINE STATE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEADACHE; HUMAN; NAUSEA; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BORDERLINE PERSONALITY DISORDER; FEMALE; HUMANS; METHYLPHENIDATE; SMOKING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349823627     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181a5d075     Document Type: Article

References (39)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text revision ed. Washington, DC: American Psychiatric Association; 1994.
2. Barkley RA, Fischer M, Edelbrock CS, et al. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990;29:546-557. (Pubitemid 20235340)
3. Barkley RA, Fischer M, Smallish L, et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279-289.
4. Distel MA, Ligthart L, Willemsen G, et al. Personality, health and lifestyle in a questionnaire family study: a comparison between highly cooperative and less cooperative families. Twin Res Hum Genet 2007;10:348-353.
5. Tercyak KP, Lerman C, Audrain J. Association of attention-deficit/ hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry 2002;41:799-805.
6. Davis RM, Wakefield M, Amos A, et al. The hitchhiker's guide to tobacco control: a global assessment of harms, remedies, and controversies. Annu Rev Public Health 2007;28:171-194.
7. Torabi MR, Bailey WJ, Majd-Jabbari M. Cigarette smoking as a predictor of alcohol and other drug use by children and adolescents: evidence of the Bgateway drug effect[. J Sch Health 1993;63: 302-306.
8. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 1998;31:533-544.
9. Milberger S, Biederman J, Faraone SV, et al. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:37-44.
10. Riggs PD, Mikulich SK, Whitmore EA, et al. Relationship of ADHD, depression, and nonYtobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug Alcohol Depend 1999;54:195-205.
11. Burke JD, Loeber R, White HR, et al. Inattention as a key predictor of tobacco use in adolescence. J Abnorm Psychol 2007;116:249-259.
12. Pomerleau OF, Downey KK, Stelson FW, et al. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995;7:373-378.
13. Mirza NR, Stolerman IP. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berl) 1998;138:266-274.
14. Ernst M, Heishman SJ, Spurgeon L, et al. Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology 2001;25:313-319.
15. Levin ED, Conners CK, Sparrow E, et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 1996;123:55-63.
16. Levin ED, Conners CK, Silva D, et al. Transdermal nicotine effects on attention. Psychopharmacology (Berl) 1998;140:135-141.
17. Levin ED, Rezvani AH. Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol 2000;393:141-146.
18. Levin ED, Conners CK, Silva D, et al. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 2001;9:83-90.
19. Lerman C, Audrain J, Tercyak K, et al. Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine Tob Res 2001;3:353-359.
20. Potter AS, Newhouse PA. Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 2004;176:182-194.
21. Tercyak KP, Audrain-McGovern J. Personality differences associated with smoking experimentation among adolescents with and without comorbid symptoms of ADHD. Subst Use Misuse 2003;38: 1953-1970.
22. Krause KH, Dresel SH, Krause J, et al. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol 2002;5:111-113.
23. Gehricke JG, Whalen CK, Jamner LD, et al. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: a preliminary examination. Nicotine Tob Res 2006;8:37-47.
24. Wing VC, Shoaib M. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. Psychopharmacology (Berl) 2007;195:303-313.
25. Robinson MD, Anastasio GD, Little JM, et al. Ritalin for nicotine withdrawal: Nesbitt's paradox revisited. Addict Behav 1995;20: 481-490.
26. Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry 2004;65:1660-1665.
27. Golubchik P, Sever J, Zalsman G, et al. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. Int Clin Psychopharmacol 2008;23: 228-231.
28. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I DisordersVClinical Version (SCID-CV). Washington, DC: American Psychiatric Press; 1997.
29. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical interview for DSM-IV Axis II Personality Disorders (SCID-II). Washigton, DC: American Psychiatric Press; 1997.
30. DuPaul G, Power T, Anasopoulos A, et al. ADHD Rating Scale-IV: Checklist, Norms, and Clinical Interpretation. New York: Guilford; 1998.
31. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-1127.
32. Ferris RM, Tang FL. Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. J Pharmacol Exp Ther 1979;210:422-428.
33. Gobbi G, Slater S, Boucher N, et al. Neurochemical and psychotropic effects of bupropion in healthy male subjects. J Clin Psychopharmacol 2003;23:233-239.
34. Wooters TE, Neugebauer NM, Rush CR, et al. Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology 2008;33:1137-1148.
35. Rush CR, Higgins ST, Vansickel AR, et al. Methylphenidate increases cigarette smoking. Psychopharmacology (Berl) 2005;181:781-789.
36. Vansickel AR, Stoops WW, Glaser PE, et al. A pharmacological analysis of stimulant-induced increases in smoking. Psychopharmacology (Berl) 2007;193:305-313.
37. Huss M, Poustka F, Lehmkuhl G, et al. No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study. J Neural Transm 2008;115:335-339.
38. McClernon FJ, Kollins SH, Lutz AM, et al. Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology (Berl) 2008;197:95-105.
39. Fossati A, Novella L, Donati D, et al. History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatry 2002;43:369-377.